The 6th Annual 5K Walk/Hike for Meso Raises Over $160,000 for Mesothelioma Research

LOS ANGELES, CALIFORNIA, UNITED STATES, November 1, 2017 /EINPresswire.com/ — The Pacific Mesothelioma Center at the Pacific Heart, Lung & Blood Institute marked its 6th annual 5K Walk/Hike for Mesothelioma on Oct 22nd, 2017, at the Paramount Ranch. With over 350 walkers, the event raised $160,495 to find better treatments for malignant pleural mesothelioma, an asbestos-related form of cancer. Mesothelioma affects almost 3,000 people in the US each year, one-third of whom are veterans.

Presented by Worthington & Caron, P.C, the event brought together people who can personally relate to the cause. Thirty-two teams, consisting of family members and friends of those who have mesothelioma, as well as supporting organizations and individual walkers, gathered at the park at 9 a.m. for check-in and team photos. Each registrant received a complimentary T-shirt, fruit products generously donated by Dole, and sunscreen before leaving on the 5K or 1-mile hike.

After the walk, participants enjoyed a catered lunch by local Agoura Hills favorite Italia Deli. The event also offered David’s Tea, Duverger Macaroons, Monster energy drinks, Mustache Mike’s Italian Ice and a concert by The Six Billion Dollar Band. The live auction featured items such as a photo safari for two in South Africa and a Maui luxury package. The silent auction and opportunity drawing featured items such as gift baskets, dining and adventure certificates and weekend getaways.

Prior to the day of the event, participants were also encouraged to fundraise on their own and compete for an engraved “Top Fundraising Team” award. Besides asking for donations, some teams took a creative route in raising their funds and awareness for the cause, such as a Pasta Party by Team Jarvis, a bake sale at UCLA for Team Cameron’s Cruisers, and a Powerball at Captain’s Treasure Chest by Team Ganoe. The top fundraising team, Double Nickels, led by team captain Cubby Winkel raised over $19,000 for mesothelioma research. Cubby Winkel walks to support his wife, Judy Winkel, a brave mesothelioma warrior.

Many walk to honor those they have lost to this devastating disease. Returning walker Philip Prokop states “I’m glad that my team and I were able to participate again in this year’s walk. It shows support from everyone there, that they appreciate the efforts that The Pacific Mesothelioma Center and Dr. Cameron and his staff are doing. I will continue to support and help any way that I can.” PMC supporter Courtney Erhart added “The Meso walk is a tradition to celebrate and remember my Mom by walking with people that loved her. It’s also a way to support families who are going through or have gone through similar challenges. It’s a terrible disease and every step towards a cure is a step worth taking”.

Donations for the 5K Walk for Mesothelioma are still being accepted at www.phlbi.org/5k-walk-for-mesothelioma.

Latest Breakthroughs In Mesothelioma Research Are Discussed At the 7th Symposium on Malignant Mesothelioma at UCLA

The Symposium Draws a Distinguished Panel of Researchers and Clinicians to UCLA to Discuss the Latest Breakthroughs in Prevention, Detection, and Treatment.

LOS ANGELES, CA, UNITED STATES, October 4, 2017 /EINPresswire.com/ — The 7th International Symposium on Malignant Pleural Mesothelioma was held on Saturday, September 30th, at the UCLA Meyer & Renee Luskin Conference Center. The focal point of the symposium was on clinical therapies and research data to prevent, detect and treat malignant pleural mesothelioma. Healthcare professionals including physicians, nurses, and scientists joined students, mesothelioma patients, and their families to attend this informative and educational conference.The Symposium was co-hosted by UCLA and the Pacific Mesothelioma Center (PMC).

The morning session was opened by symposium chair, Dr. Robert B. Cameron, MD, FACS, who discussed The future of mesothelioma surgery.“Although surgery in mesothelioma has decreased due to a perceived lack of efficacy among oncologists and other physicians, there are therapies, such as preoperative radiation, cryoablation, and Betadine lavage, which are keeping surgical results ahead of other therapies,” said Dr. Cameron, Professor of Clinical Cardiothoracic Surgery and Surgical Oncology. The highlights of his presentation centered on how these therapies supplemented standard of care treatments through preoperative, intraoperative, and postoperative therapeutic modalities. Dr. Cameron is a pioneer in the field of mesothelioma, Director of the Comprehensive Mesothelioma Program at UCLA, Senior Professor of Surgery at UCLA, and Chief of Thoracic Surgery at the West Los Angeles Veterans Affairs Medical Center.

“This year has been incredibly hopeful as there are new biological advances, such as immunotherapy, anti-angiogenic therapy, and others, that are likely to lead to improved treatments in the future,” said Dr. Cameron. Immunotherapy is advancing rapidly and many other therapies, such as thermal, chemical, gene and cell-based therapies are on the horizon”.

Additional presentation topics included Immune Checkpoint Blockade in MPM; Recent Findings of Mesothelioma and BAP1; Intracavitary Therapeutics for MPM; Disabling Mitochondrial Peroxide Metabolism as an Effective Therapeutic Approach to MPM; Targeting the Epigenome in MPM; Engineering Mesenchymal Stem Cells for Immunotherapy of MPM; Inflammasome Modulation by Chemotherapeutics in MPM; The Benefits of a Mesothelioma Caregiver Support Group and Resources for Research – the Student Internship Program.

The symposium’s other distinguished faculty included: Anna Nowak, PhD of the University of Western Australia; Luana Calabrò, MD, University Hospital of Sienna, Italy; David S. Schrump, MD, National Cancer Institute, Maryland; Jacques P. Fontaine, MD, Moffitt Cancer Center, Tampa; Brian Cunniff, PhD, University of Vermont; Haining Yang, MD, PhD, University of Hawaii; Arti Shukla, PhD, University of Vermont; Olga Olevsky, MD, UCLA; Lien Hua-Feng NP, UCLA/VA/PHLBI and Clare Cameron, Executive Director of the PHLBI.

The symposium was supported by: Worthington & Caron PC, The International Association of Heat & Frost Insulators, and Waters Kraus & Paul.

Making Strides for Mesothelioma Research: At the 6th Annual 5K Walk/Hike for Mesothelioma

Grab Your Walking Shoes and Join Us for the 6th Annual 5K Walk/Hike for Mesothelioma Research on Sunday, October 22nd at The Paramount Ranch in Agoura Hills

 

LOS ANGELES, CALIFORNIA, U.S., September 13, 2017 /EINPresswire.com/ — The Pacific Mesothelioma Center (PMC) a division of the Pacific Heart, Lung & Blood Institute (PHLBI) will hold its sixth annual 5K Walk/Hike for Meso on October 22, 2017, at the Paramount Ranch in Agoura Hills, CA. This year the walk will be hosted by CHiPS star and longtime Pacific Mesothelioma Center supporter Larry Wilcox who will use his humor and wit in his role as MC. With the previous year’s success of over 400 participants and $122,000 raised, the Pacific Mesothelioma Center is setting an ambitious $150,000 goal for the walk this year. The PMC’s mission is to find better treatment options for malignant pleural mesothelioma (MPM), a devastating cancer caused by exposure to asbestos with sadly few treatment options. Mesothelioma affects thousands of people each year with a disproportionate number of those being veterans. The annual 5K walk raises awareness for mesothelioma and provides financial support for pioneering mesothelioma research.

The 5K Walk for Mesothelioma, presented by Worthington & Caron P.C, is the only annual 5K walk on the West Coast held to raise funds for mesothelioma research. Over the years the walk has brought together people who can personally relate to the cause and as a result, has fostered a community. Teams, consisting of family members and friends of those who died of mesothelioma, as well as supporting organizations and individual walkers, will gather together on October 22nd to raise awareness and funds.

The cost of registering for the walk is $45 online and $50 the day of the walk. Children 12 and under are admitted for free. Each registrant receives a light breakfast of donated fruit, muffins and coffee, and a PMC walk T-shirt before leaving on the 5K or 1-mile hike, and a medal upon completion. For participants that do not want to walk or hike, bingo will be available. Create a team, join a team, or register as an individual here: http://www.phlbi.org/5k-walk-for-mesothelioma/ .

After the 5K there will be a catered lunch by famed Agoura Hills restaurant Italia’s Deli, delicious Duvurger macaroons, live entertainment by The Six Billion Dollar Band, live auction, and an opportunity drawing. The opportunity drawing and auction offer great prizes including weekend getaways, exciting experiences, great restaurant packages, fun excursions, gift certificates, jewelry, and much more. All of the proceeds go directly to mesothelioma research.

“We are walking in honor of my father, Sal Oliveri and his team “Sal’s Meso Warriors”, said Nick Oliveri of Thousand Oaks. “My father recently underwent surgery by mesothelioma specialist, Dr. Robert B. Cameron to remove his mesothelioma tumors. We are overjoyed that he has been given a shot at extending his life and can think of no better way to show our support of this institute and to help raise funds for their important research program”.

 

The Pacific Meso Center Receives $100,000 Towards the Anonymous $1 Million Challenge Pledge to Help Fight Mesothelioma

LOS ANGELES, CA, U.S., August 30, 2017 /EINPresswire.com/ — The Pacific Mesothelioma Center (PMC), a division of the Pacific Heart, Lung & Blood Institute (PHLBI), is pleased to announce a generous $100,000 gift from Roger G. Worthington, of the law office Worthington & Caron P.C. This donation, made in response to the anonymous $1 million challenge grant the PMC recently received, will be used to further the PMC’s groundbreaking research on malignant pleural mesothelioma, asbestos-related cancer affecting the lining of the chest.

The gift will be used in support of NHLBI’s two new scientists – Dr. Masahide Tone and Dr. Yukiko Tone. Both scientists have worked at Cambridge University, Oxford University, University of Pennsylvania and Cedars Sinai Medical Center. They will work on novel immunotherapies for mesothelioma. Immunotherapy is an exciting and promising cancer treatment that uses the body’s immune system to fight cancer. It is the PMC’s firm belief that the future of mesothelioma treatment will involve combination therapy, including surgery, radiation, chemotherapy, and immunotherapy. Further, rational combinations of various immunotherapies combined with traditional cancer therapies holds the greatest promise for real progress in the treatment of mesothelioma and other cancers.

Roger Worthington is a long-time advocate for mesothelioma research. In 2005, in honor of his father Punch Worthington, Ph.D., Roger helped establish the David “Punch” Worthington Lab at the David Geffen School of Medicine at the UCLA Medical Center in Los Angeles. The Punch Worthington Lab. is the home of innovative research on novel strategies for the treatment of mesothelioma, lung cancer, and other occupational cancers. Sadly, his father passed away in 2006 from lung-cancer caused by asbestosis.

“We certainly are pleased to provide PMC with additional funds towards the anonymous $1 million matching gift that the institute recently received and I encourage others to donate, no matter how small”, said Roger Worthington, a long-term supporter of the PMC and principal of the Law Office of Worthington and Caron PC. “These funds will enable the PMC to continue their great work on mesenchymal stem cells with their groundbreaking research which holds immense potential to lead to effective treatments not only for mesothelioma but perhaps for many other cancers as well.”

“We are very fortunate to have the continued support of Mr. Worthington,” Dr. Cameron said. “We are tremendously indebted to him and to all those who contribute to PHLBI. This money will allow us to accelerate our search for novel therapies to improve both the longevity and the quality of life of those battling mesothelioma, lung cancer and other diseases of the chest.”

Dr. Cameron is a pioneer in the field of mesothelioma, Director of the Comprehensive Mesothelioma Program at UCLA, Professor of Surgery at UCLA and Chief of Thoracic Surgery at the West LA Veterans Affairs Medical Center. He is also one of the PMC’s Scientific Advisors.

Matching gifts can be made either by mail or online, at http://www.phlbi.org/about/get-involved/donate/.

Cutting-edge Research to be Presented at 7th Annual International Symposium on Mesothelioma at UCLA

LOS ANGELES, CA, UNITED STATES, August 24, 2017 /EINPresswire.com/ — On September 30th global experts on malignant pleural mesothelioma will again convene at the Meyer & Renee Luskin Conference Center at UCLA for the 7th Annual International Symposium on Malignant Pleural Mesothelioma (MPM), a rare form of cancer that results from exposure to asbestos and commonly affects the lining of the chest– the pleura. The event is jointly hosted by UCLA and the Pacific Mesothelioma Center (PMC).

The Symposium is geared towards physicians and offers continuing medical education (CME) credit. It will also provide up-to-date information on mesothelioma for medical students, nurses and other healthcare professionals, as well as mesothelioma patients, their families and other interested parties. Topics will cover: Surgery for Mesothelioma; Immune Checkpoint Blockades; Combining Angiogenesis Inhibition with Chemotherapy; Disabling Mitochondrial Peroxide Metabolism as an Effective Therapeutic Approach; Targeting the Epigenome in MPM; Recent Findings on Mesothelioma and BAP1 and more.

The Symposium will be led by Robert B. Cameron, MD, FACS, Director of the UCLA Mesothelioma Comprehensive Research Program and Chief of Thoracic Surgery at the West Los Angeles VA Medical Center. The roster of distinguished international faculty at the Symposium will include Anna Nowak, PhD of the University of Western Australia; Luana Calabrò, MD, University Hospital of Sienna, Italy; David S. Schrump, MD, National Cancer Institute, Maryland; Jacques P. Fontaine, MD, Moffit Cancer Center, Tampa; Brian Cunniff, PhD, University of Vermont; Haining Yang, MD, PhD, University of Hawaii; Arti Shukla, PhD, University of Vermont as well as local experts from UCLA.

“This event highlights the most promising medical advances in the treatment of mesothelioma as well as promising new research,” said Dr. Cameron. “Over the past five years we’ve seen unprecedented advances in mesothelioma research that we never would have predicted a decade ago. Our intensive collaborations between laboratory and clinical scientists are yielding new insights into promising future treatments for mesothelioma such as immunotherapy, which is the most recent breakthrough for treating cancer. The symposium gives an unrivaled opportunity for both the medically savvy and general public, including mesothelioma patients, to not only learn first-hand about groundbreaking discoveries, but also to exchange ideas.”

The Symposium is supported by: Worthington & Caron, P.C., Waters, Kraus & Paul, Asbetos.com and the International Association of Heat & Frost Insulators.

Early Bird tickets can be purchased before September 6th online at http://www.cme.ucla.edu/courses/.

The Pacific Mesothelioma Center Receives $1 Million Anonymous Challenge Grant to Help Fight Mesothelioma

LOS ANGELES, CA, USA, August 15, 2017 /EINPresswire.com/ — The Pacific Mesothelioma Center (PMC), a division of The Pacific Heart, Lung & Blood Institute (PHLBI), is pleased to announce a generous $1 million grant from an anonymous donor. The challenge grant is committed over the next four years with the challenge for the PMC to raise matching funds for additional immunotherapy research.

The grant will be used to support a molecular biologist and an immunologist working on novel immunotherapies for mesothelioma. Malignant pleural mesothelioma is an asbestos-related cancer that affects the lining of the chest – the pleura. Immunotherapy is an exciting and promising cancer treatment that uses the body’s immune system to fight cancer. It is the PMC’s firm belief that the future of mesothelioma treatment will involve combination therapy, including surgery, radiation, chemotherapy and immunotherapy. Further, rational combinations of various immunotherapies combined with traditional cancer therapies, holds the greatest promise for real progress in the treatment of mesothelioma and other cancers. The donation will help propel this initiative forward.

Upon an annual review by the anonymous donor, a grant of up to $250,000 will be awarded each year until 2021. Gifts can be made by mail (10780 Santa Monica Blvd, Suite 101, Los Angeles, CA 90025) or online, at http://www.phlbi.org/about/get-involved/donate/.

As a result of this generous grant, the PMC are pleased to announce the appointment of two new Molecular Immunologists who have worked at the Universities of Cambridge and Oxford, the University of Pennsylvania and Cedars Sinai Medical Center. Masahide Tone, Ph.D will bring his immense knowledge, vast skills and leadership capabilities to the PMC lab as Senior Researcher and Director of Research. Yukiko Tone, DSc will be a senior research scientist. Their positions commence on August 21st, 2017.

“This pledge comes at a really exciting time in immunotherapy research,” said Dr. Robert B. Cameron. “For the first time ever, we are seeing real benefit of immunotherapy for malignant pleural mesothelioma. Combining different immunotherapies with more traditional cancer treatments, like surgery, in rational ways holds great promise for finally improving the survival of patients with this formerly fatal disease.”

Dr. Cameron is a pioneer in the field of mesothelioma, Director of the Comprehensive Mesothelioma Program at UCLA, Professor of Surgery at UCLA and Chief of Thoracic Surgery at the West LA Veterans Affairs Medical Center. He is also one of the PMC’s Scientific Advisors.

The Pacific Mesothelioma Center (PMC) Is Pleased To Announce The Appointment of Michael Arlen To The Board of Directors

Michael Arlen is focused on helping PMC raise greater awareness of mesothelioma.

Michael ArlenLOS ANGELES, CALIFORNIA, U.S., August 1, 2017 /EINPresswire.com/ — The Pacific Mesothelioma Center, a division of the Pacific Heart, Lung & Blood Institute, is pleased to announce the appointment of Michael Arlen to its Board of Directors. Michael is an entrepreneur with extensive experience in both business and serving on non-profit boards. He launched a local Los Angeles ad agency which, over the course of 16 years, grew into one of Los Angeles’ top billing ad agencies with offices in, Taipei, Hong Kong, Tokyo, Singapore & Mexico City. He also helped design and popularize the NIH’s emergency medical protocols for the treatment heart attacks for adults, children and neonates; and asthma guidelines. His pocket references helped usher-in triage-centric education in medical schools and provided coursework for allied healthcare professionals to become certified to deliver emergency care, including the administration of drugs, at the scene, before a patient was able to see a doctor. His latest company, NEWtritious develops functional foods, designed to make it easier for patients in healthcare facilities to receive their Daily Value of protein, essential vitamins and minerals.

Michael earned his Juris Doctorate degree from Loyola Law School, Los Angeles and a Bachelor of Science in Anthropology at UCLA. He has served on the Boards of the American Lung Association for 12 years and Breathe LA for 14 years.

“I have great interest in PHLBI’s mission to advance medical research, as my family has been touched by illnesses of both the heart and the lung,” said Michael. “I feel very passionate about Board service and helping causes concerning health and wellness. I’m looking forward to learning more about how I can best be of service to the PHLBI.

“Michael has demonstrated diverse professional skill sets through the various companies he has founded and ran and has extensive experience in executive leadership at several national non-profits. I love his creativity and giving spirit and we are most fortunate that he has chosen our organization, and we all look forward to learning from him” said Rhonda Ozanian, chair of the board of directors at the PHLBI.

Pacific Meso Center’s “Greatest Escape” Motorcycle Ride Raises Funds and Awareness for Mesothelioma Research

LOS ANGELES , CA, U.S., June 16, 2017 /EINPresswire.com/ — The Pacific Mesothelioma Center (PMC) at the Pacific Heart, Lung & Blood Institute (PHLBI) held its 5th annual “Greatest Escape” Motorcycle Ride on Sunday, June 4. The ride, inspired by The Great Escape movie and starring actor, motorcycle enthusiast, and mesothelioma sufferer, Steve McQueen, is a unique event which honors those who have lost the fight against mesothelioma and raises money for research.

This year’s event enjoyed its biggest turnout ever! Over 200 riders participated and $78,657 was raised for mesothelioma research. For the first time, the ride kicked off from two locations-Top Rocker Harley-Davidson in Canoga Park and Antelope Valley Harley-Davidson in Lancaster. Officers from All Cities Transportation Company escorted riders out of Los Angeles with zero stops—a true luxury for riders accustomed to LA gridlock. From there, all roads led to the “twisties” and breathtaking vistas of Angeles Crest Highway on the way to historic Newcomb’s Ranch.
Riders were joined by a cast of celebrity riders, including actor/model, Fabio, Shades of Blue actor Antonio Jaramillo, American Crime actor Clayton Cardenas, and CHiPS star Larry Wilcox. Fabio, who returned for the third year as Celebrity Grand Marshal, summed up the experience, “I had a great time, it’s such a beautiful ride, one of the most beautiful rides in California”.

Things heated up at Newcomb’s Ranch where riders were joined by supporters who drove up to be part of the event and make a difference for mesothelioma sufferers. “The Sidemen” kept the event rocking with a lively mix of classic rock and blues. Fred and his crew at Newcomb’s rolled out an amazing taco lunch which many enjoyed with cold craft beer donated by Bend, Oregon brewery, Worthy Brewing. An array of vendors were there with a unique mix of items ranging from motorcycle gear to Italian ices. Also on display were over 50 raffle items including gourmet dinners, a vacation getaway to the Glen Tavern Inn, motorcycle gear, and so much more generously donated by sponsors.
With the addition of the second starting location, riders from all over Southern California were able to participate in this worthwhile event. “Motorcycle riders love the freedom of being on their bikes and going to out of the way places like Newcomb’s Ranch,” said John Caron of presenting sponsor, Worthington & Caron Asbestos Law Firm, “so it’s no surprise that more and more riders show up every year to help those who have lost their freedom to mesothelioma.”
PMC thanks everyone who participated in this year’s Greatest Escape, along with all the volunteers and sponsors who make this unique event possible.

 

PMC Clinical Research Study Uses Fitness Device to Monitor Patient’s Recovery After Surgery

Background

The student intern program at PHLBI was established in 2016 to allow students to have on the site training at PHLBI’s in-house laboratory.  When students are not assisting Lead Researcher Ray Wong they are encouraged to engage in their own research projects.  One such project is clinical research centered on measuring a patient’s recovery after surgery led by student intern Blair Kimble.  Kimble has worked closely with PHLBI staff to recruit patients and monitor their recovery by loaning them FitBit devices that in turn will monitor how much activity they are getting, how much they are sleeping, what their heart rate is, and other valuable health information items on the patient.  Below Kimble discusses her project at greater length including what she hopes the research will ultimately demonstrate.

About the Study

When a surgery is successful, its success is not determined as the incisions are closed up. A surgery is a success when the patient has a smooth recovery and can return back to their daily lives. The comfort and recovery of a patient is a top priority for physicians, but the amount of time available every day to evaluate that recovery is incredibly limited. In having such a small window in which to evaluate a patients progress, a physician may not be able to see everything relevant.

With PHLBI’s newest clinical research project, we have designed a way we hope to measure patient recovery. In giving patients a Fitbit® activity monitor, we are able to collect data about their walking, their heart rate, and their sleep both before and after surgery. Using their data from before surgery as a baseline for their activity, we are then able to track how quickly they return to that normal baseline after surgery.

This research investigates some of the first quantitative measures of surgical patient recovery ever collected. Until now, recovery has been evaluated subjectively, but with objective data, we may be able to correlate certain kinds of physiological factors with a faster discharge from the hospital and smooth recovery after going home from the hospital. We expect that constant monitoring of patients in a quantitative, objective manner will be a more reliable and complete representation of their recovery than anything that has been collected before.

We are currently in the pilot portion of the research, focusing on making sure the data collected is accurate. We plan to soon move on to running a randomized trial where some patients will get access to their activity data measured by the Fitbit® and some will not. This will allow us to compare the pace of recovery between those who get feedback and those who not and hopefully show that the quantitative data is motivating for patients. We hope to ultimately demonstrate that with an activity monitor, we can help patients recover to their own baseline of activity faster and return to their daily life.

About the Author

unnamed

Blair Kimble is a third year undergraduate student at UCLA. She has been working at PHLBI for two years and has spent one year developing this clinical research. She also does immunotherapy research and plans to apply to medical school this summer. Blair practices martial arts and loves to cook.

Two New Board Members Join The Pacific Mesothelioma Center to Help Fight Mesothelioma

Kellie Sutherland (2)

LOS ANGELES, April 10th 2017 – The Pacific Heart, Lung & Blood Institute (PHLBI), a division of which is the Pacific Mesothelioma Center (PMC), has announced the appointment of Kellie Sutherland and Joseph Garland to its board of directors.

Kellie, an engineer who has worked with Northrop-Grumman for the past nine years, received her Masters of Arts in Organization Management and a Bachelors of Science in Business Management at the University of Phoenix. Kellie has volunteered for the Institute for the last 2 years, arranging health fairs and lunch meetings to raise awareness for mesothelioma and has headed up a Northrop- Grumman walk team each year. She is appointed to the role of Secretary of the Board.

“I was impressed with this organization from the very beginning and that is why I have carried a banner for them. Now I am more than excited about being part of this board at this important time for the Institute as they make big strides in their mesenchymal stem cell research” said Kellie. I am honored to be working with such an amazing and dedicated team”.

Joseph Garland (21)The second appointment to the board is Joseph Garland, who is the Managing Partner and CEO at Centennial Harvest Group. Joseph has over 20 years in healthcare. He is board certified in Healthcare management and holds the distinction of Fellow, American College of Healthcare Executives.

He received an MBA in Health Services Management at Keller Graduate School of Management and a Masters in Health Administration from USC. Joseph is committed to advancing public health while improving Healthcare organization’s outcomes and sustainability.

“What interests me most about committing my time and energy to PHLBI is their mission and commitment to health advancements through research and innovation, and as such I feel the PMC’s mission is a good fit for me” Joseph stated.

“We are delighted with the appointment of both these dedicated and passionate individuals to the board of directors at a crucial time as we move forward in our fight to defeat mesothelioma”, said Rhonda Ozanian, chair of the board of directors at the PMC.